Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,440.27
    +1,265.56 (+2.52%)
     
  • CMC Crypto 200

    1,367.90
    +55.28 (+4.22%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Global Patient Monitoring Devices Market (2020 to 2026) - by Type, End-user and Geography

Dublin, Nov. 13, 2020 (GLOBE NEWSWIRE) -- The "Patient Monitoring Devices Market by Type, End User and Geography Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Patient monitoring devices are used to monitor the patient's health condition, which helps professionals to keep a watch on the patient's condition. The patient monitoring device calculates, record, deliver and shows the final results of biometric values such as heart rate, oxygen saturation, blood pressure, and more.

The patient monitoring device market is growing enormously, and the factors contributing towards enhancing the market growth are wireless patient monitoring devices, which are very in demand. Wireless patient monitoring devices involve monitoring the patient's vitals remotely through devices that transfer a patient's health data to other locations of wireless technology.

Also, rapid growth in the elderly population increases the prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular. Somehow, the adoption of advanced patient monitoring devices by professionals is difficult, and this is a restrain to market growth. The patient monitoring devices market is estimated to grow at a CAGR of 5.6% throughout the study period, it predicted to reach from $23 billion in 2020 and anticipate to reach a value of $32 billion in 2026.

Globally, the demand for patient monitoring devices has increased due to the evolving lifestyle and chronic diseases such as diabetes, cancer, and others, a rise in the elderly population along with improvised technologies in this field, such as wireless remote monitoring. The increasing adoption of the patient monitoring devices in non-hospital settings such as home settings and ambulatory surgery centers which provide the opportunity for the market.

The major market players in the patient monitoring devices market include Boston Scientific Corporation, Hill-Rom Holdings, Medtronic, Nihon Kohden, Natus Medical, Koninklijke Philips N.V., Edward Lifesciences, Omron, Masimo, GE Healthcare, Hill-Rom Holdings, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Schiller g, Dragerwerk Ag, Compumedics, BTL, Biotronik, Biotelemetry, and Abbott Laboratories.

Globally, the developing countries are the future markets that are expected to provide new opportunities for the patients monitoring device market growth. This report will provide companies to understand the trends, market dynamics, and end-user requirements. The detailed analysis based on qualitative and quantitative factors provides a comprehensive view of the market.

  • The research analysis of the major players helps users to understand the dynamic strategies of the key players including product innovation, joint ventures, merger & acquisitions, and partnerships

  • This report also gives detailed portfolio analysis and capability analysis for the key players

  • Quantitative analysis provides facts about the market

Key Topics Covered:

1. Executive Summary

2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends

3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets

4. Market characteristics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis

5. Type: Market Size & Analysis
5.1. Overview
5.2. Hemodynamic Monitoring Devices
5.2.1. Devices
5.2.2. Disposables
5.3. Neuromonitoring Devices
5.3.1. Cerebral Oximeters
5.3.2. Electroencephalograph (EEG) Machines
5.3.3. Electromyograph (EMG) Machines
5.3.4. Electrophysiological (EP) Monitoring
5.3.5. Intracranial Pressure Monitors
5.4. Cardiac Monitoring Devices
5.4.1. ECG Devices
5.4.2. Event Monitors
5.4.3. Implantable Loop Recorders
5.4.4. Mobile Cardiac Telemetry Monitors
5.4.5. Smart Wearable ECG Monitors
5.5. Fetal & Neonatal Monitoring Devices
5.5.1. Ultrasound
5.5.2. Fetal Monitoring Devices
5.5.3. Neonatal Monitoring Devices
5.6. Respiratory Monitoring Devices
5.6.1. Pulse Oximeters
5.6.2. Spirometers
5.6.3. Capnographs
5.6.4. Peak Flow Meters
5.7. Multiparameter Monitoring Devices
5.7.1. Low-Acuity Monitoring Devices
5.7.2. Mid-Acuity Monitoring Devices
5.7.3. High-Acuity Monitoring Devices
5.8. Temperature Monitoring Devices
5.9. Weight Monitoring Devices
5.10. Others

6. Geography: Market Size & Analysis
6.1. Overview
6.2. North America
6.3. Europe
6.4. Asia Pacific
6.5. Rest of the World

7. Competitive Landscape
7.1. Competitor Comparison Analysis
7.2. Market Developments
7.3. Mergers and Acquisitions, Legal, Awards, Partnerships
7.4. Product Launches and execution

8. Vendor Profiles
8.1. Medtronic
8.1.1. Overview
8.1.2. Product Offerings
8.1.3. Geographic Revenue
8.1.4. Business Units
8.1.5. Developments
8.1.6. Business Strategy
8.2. Nihon Kohden
8.2.1. Overview
8.2.2. Product Offerings
8.2.3. Geographic Revenue
8.2.4. Business Units
8.2.5. Developments
8.2.6. Business Strategy
8.3. Natus Medical
8.3.1. Overview
8.3.2. Product Offerings
8.3.3. Geographic Revenue
8.3.4. Business Units
8.3.5. Developments
8.3.6. Business Strategy
8.4. Koninklijke Philips N.V.
8.4.1. Overview
8.4.2. Product Offerings
8.4.3. Geographic Revenue
8.4.4. Business Units
8.4.5. Developments
8.4.6. Business Strategy
8.5. Edward Lifesciences
8.5.1. Overview
8.5.2. Product Offerings
8.5.3. Geographic Revenue
8.5.4. Business Units
8.5.5. Developments
8.5.6. Business Strategy
8.6. Omron
8.6.1. Overview
8.6.2. Product Offerings
8.6.3. Geographic Revenue
8.6.4. Business Units
8.6.5. Developments
8.6.6. Business Strategy
8.7. Masimo
8.7.1. Overview
8.7.2. Product Offerings
8.7.3. Geographic Revenue
8.7.4. Business Units
8.7.5. Developments
8.7.6. Business Strategy
8.8. GE Healthcare
8.8.1. Overview
8.8.2. Product Offerings
8.8.3. Geographic Revenue
8.8.4. Business Units
8.8.5. Developments
8.8.6. Business Strategy
8.9. Hill-Rom Holdings
8.9.1. Overview
8.9.2. Product Offerings
8.9.3. Geographic Revenue
8.9.4. Business Units
8.9.5. Developments
8.9.6. Business Strategy
8.10. Dragerwerk Ag
8.10.1. Overview
8.10.2. Product Offerings
8.10.3. Geographic Revenue
8.10.4. Business Units
8.10.5. Developments
8.10.6. Business Strategy

9. Companies to Watch
9.1. Compumedics
9.1.1. Overview
9.1.2. Market
9.1.3. Business Strategy
9.2. Shenzhen Mindray Bio-Medical Electronics
9.2.1. Overview
9.2.2. Market
9.2.3. Business Strategy
9.3. Abbott Laboratories
9.3.1. Overview
9.3.2. Market
9.3.3. Business Strategy
9.4. Boston Scientific Corporation
9.4.1. Overview
9.4.2. Market
9.4.3. Business Strategy
9.5. Biotronik
9.5.1. Overview
9.5.2. Market
9.5.3. Business Strategy
9.6. Hill-Rom Holdings
9.6.1. Overview
9.6.2. Market
9.6.3. Business Strategy
9.7. BTL
9.7.1. Overview
9.7.2. Market
9.7.3. Business Strategy
9.8. Biotelemetry
9.8.1. Overview
9.8.2. Market
9.8.3. Business Strategy
9.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.9.1. Overview
9.9.2. Market
9.9.3. Business Strategy
9.10. Schiller g
9.10.1. Overview
9.10.2. Market
9.10.3. Business Strategy

10. Analyst Opinion

11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting

12. Report Assumptions

13. Declarations

14. Stakeholders

15. Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/63es8r

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

ADVERTISEMENT
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900